Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shuai Yang
Observed names:
S. Yang,
Yang, Shuai
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Shanghai Public Health Clinical Center,
Huashan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Guangdong Medical College,
Fudan University,
Shanghai Public Health Clinical Center,
Huashan Hospital
ORCID:
0000-0002-5096-4356
Observed ORCID:
0000-0002-5096-4356
OpenAlex ID:
A5120061451
SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network
2022
·
Wei Li
, Shuai Yang
, et al.
·
EBioMedicine
·
48
Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression
2022
·
Shuai Yang
, Yun Ling
, et al.
·
Signal Transduction and Targeted Therapy
·
45
PDF
Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis
2022
·
Yao Lin
, Yiming Shao
, et al.
·
Renal Failure
·
28
NamiRNA‐Enhancer Network: The Changing Era Challenge and Chance of miRNA
2025
·
Lu Chen
, Ying Liang
, et al.
·
Advanced Science
·
12
PDF
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
2022
·
Shuai Yang
, Ying Tong
, et al.
·
Molecular Biomedicine
·
12
PDF
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development
2025
·
Lu Chen
, Wenxuan Li
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
9
Evaluation of pulmonary ventilation in COVID-19 patients using oxygen-enhanced three-dimensional ultrashort echo time MRI: a preliminary study
2021
·
F. Zhao
, L. Zheng
, et al.
·
Clinical Radiology
·
9
PDF
miR‐1246 promotes osteosarcoma cell migration via NamiRNA‐enhancer network dependent on Argonaute 2
2024
·
Shuai Yang
, Qingping Zou
, et al.
·
MedComm
·
7
Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19
2022
·
Shuai Yang
, Lu Chen
, et al.
·
Acta Pharmaceutica Sinica B
·
2
PDF
Show more works
View as search
Works count:
11
Citation count:
172
H-index:
7
I10-index:
5
Year
Topic
Type